Will Zoetis be gobbled up by Bayer?

Consolidation continues in the Pharmaceutical industry

A recent article in Bloomberg News argues the case for such an acquisition. 

Bloomberg places Zoetis No. 1 in the global animal-health business, with $4.56 billion in revenue last year. Bayer is in fifth place, with 1.31 billion euros in last year’s sales after Merck & Co. (MRK), Sanofi (SAN) and Eli Lilly.

Read the article